Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/14/2023 | Galera Therapeutics, Inc. | GRTX | Grant | Stock Option (Right to Buy) | 64k | $3.27 | $209.3k | | 06/14/2023 |
06/15/2022 | Galera Therapeutics, Inc. | GRTX | Grant | Stock Option (Right to Buy) | 20k | $1.48 | $29.6k | | 06/15/2022 |
05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 30k | $5.19 | $155.7k | | 05/31/2022 |
05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 10k | $6.27 | $62.9k | | 05/31/2022 |
05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 30k | $10.95 | $328.5k | | 05/31/2022 |
08/09/2021 | Checkmate Pharmaceuticals, Inc. | CMPI | Grant | Stock Option (Right to Buy) | 30k | $5.19 | $155.7k | | 08/09/2021 |
06/16/2021 | Galera Therapeutics, Inc. | GRTX | Grant | Stock Option (Right to Buy) | 13.2k | $8.90 | $117.3k | | 06/16/2021 |
06/16/2021 | Checkmate Pharmaceuticals, Inc. | CMPI | Grant | Stock Option (Right to Buy) | 10k | $6.27 | $62.9k | | 06/16/2021 |
11/10/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Grant | Stock Option (Right to Buy) | 30k | $10.95 | $328.5k | | 11/10/2020 |
08/11/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Conversion | Common Stock | 3.5M | $0.00 | $0 | See footnote | 08/11/2020 |
08/11/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Purchase | Common Stock | 133.3k | $15.00 | $2M | See footnote | 08/11/2020 |
08/11/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Conversion | Series A Preferred Stock | 12.5M | $0.00 | $0 | See footnote | 08/11/2020 |
08/11/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Conversion | Series B Preferred Stock | 8.8M | $0.00 | $0 | See footnote | 08/11/2020 |
08/11/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Conversion | Series C Preferred Stock | 3.6M | $0.00 | $0 | See footnote | 08/11/2020 |
06/09/2020 | Galera Therapeutics, Inc. | GRTX | Grant | Stock Option (Right to Buy) | 13.2k | $9.31 | $122.7k | See footnote | 06/09/2020 |
11/06/2019 | Galera Therapeutics, Inc. | GRTX | Grant | Stock Option | 19.8k | $12.00 | $237.3k | See footnote | 11/06/2019 |
06/05/2019 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 10k | $7.30 | $73k | | 06/05/2019 |
06/13/2018 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 10k | $9.36 | $93.6k | | 06/13/2018 |
01/26/2018 | SYNLOGIC, INC. | SYBX | Grant | Common Stock | 150k | $9.75 | $1.5M | See Footnote | 01/26/2018 |
12/29/2017 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 18.6k | $9.70 | $180.1k | | 12/29/2017 |
08/28/2017 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 1.4k | $12.07 | $17.2k | | 08/28/2017 |
10/31/2016 | Ocera Therapeutics, Inc. | OCRX | Other (acquisition) | Common Stock | 700k | $0.00 | $0 | See footnote | 09/12/2016 |
10/31/2016 | Ocera Therapeutics, Inc. | OCRX | Other (acquisition) | Common Stock | 138.7k | $0.00 | $0 | See footnote | 09/12/2016 |
10/31/2016 | Ocera Therapeutics, Inc. | OCRX | Other (acquisition) | Common Stock | 9.5k | $0.00 | $0 | See footnote | 09/12/2016 |
10/31/2016 | Ocera Therapeutics, Inc. | OCRX | Other (acquisition) | Common Stock | 14.3k | $0.00 | $0 | See footnote | 09/12/2016 |
09/12/2016 | Ocera Therapeutics, Inc. | OCRX | Sale | Common Stock | 5.4k | $2.29 | $12.3k | See footnote | 09/12/2016 |
09/12/2016 | Ocera Therapeutics, Inc. | OCRX | Sale | Common Stock | 1.1k | $2.29 | $2.4k | See footnote | 09/12/2016 |
09/12/2016 | Ocera Therapeutics, Inc. | OCRX | Sale | Common Stock | 74 | $2.29 | $169.6 | See footnote | 09/12/2016 |
09/12/2016 | Ocera Therapeutics, Inc. | OCRX | Exercise (in-the-money or at-the-money) | Stock warrant (right to buy) | 9.2k | $0.67 | $6.2k | See footnote | 09/12/2016 |
09/12/2016 | Ocera Therapeutics, Inc. | OCRX | Exercise (in-the-money or at-the-money) | Stock warrant (right to buy) | 1.8k | $0.67 | $1.2k | See footnote | 09/12/2016 |
09/12/2016 | Ocera Therapeutics, Inc. | OCRX | Exercise (in-the-money or at-the-money) | Stock warrant (right to buy) | 125 | $0.67 | $83.8 | See footnote | 09/12/2016 |
07/11/2016 | Ocera Therapeutics, Inc. | OCRX | Exercise | Stock Option (Right to Buy) | 12k | $1.26 | $15.1k | | 07/11/2016 |
06/29/2016 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (Right to Buy) | 10k | $4.74 | $47.4k | | 06/29/2016 |
06/14/2016 | Ocera Therapeutics, Inc. | OCRX | Grant | | 12.5k | $2.26 | $28.2k | | 06/14/2016 |
10/06/2015 | SYNLOGIC, INC. | SYBX | Purchase | Common Stock | 857.1k | $7.00 | $6M | See Footnote | 10/05/2015 |
|